Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT06740383. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT06740383
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
SchizophreniaOtherFrom 18 Years to 40 Years
Key information made simple
This observational study is following people with psychosis or bipolarity to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
Your next step
The official record suggests in-person participation through a hospital, with sites including Hartford Hospital, University of Georgia in Athens, and University of Chicago Medical Center. Participation appears to center on assessments, scans, or samples rather than trying a new treatment. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include major medical issues that could make participation unsuitable and active substance or alcohol problems that could affect the results. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Beth Israel Deaconess Medical Center
- Sponsor type
- Hospital / academic medical center
- Main activity
- observational follow-up
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Condition
- Schizophrenia Spectrum and Other Psychotic Disorders; Schizophrenia; Delusional Disorder; Bipolar 1 Disorder; Schizoaffective Disorder; Psychosis Not Otherwise Specified; Early Psychosis
- Study status
- Recruiting
- Sponsor / lead affiliation
- Beth Israel Deaconess Medical Center
- Location / country
- United States
- Contact
- Matcheri S. Keshavan, MD, Brendan Stiltner, BA, Godfrey Pearlson, MA, MBBS, Brett Clementz, PhD, Sarah K. Keedy, PhD, Elliot S. Gershon, MD, Sarah S. Keedy, PhD, Kathryn E. Lewandowski, PhD, Kathryn E Lewandowski, PhD, Carol Tamminga, MD
- mkeshava@bidmc.harvard.edu, bstiltne@bidmc.harvard.edu, Godfrey.Pearlson@HHChealth.org, clementz@uga.edu, skeedy@bsd.uchicago.edu, egershon@bsd.uchicago.edu, klewanowski@mclean.harvard.edu, carol.tamminga@UTSouthwestern.edu
- Phone
- 617-754-1256, 860.545.7757, 706-542-2174, 773-834-7178, 617-855-2886, 214-404-2284
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06740383
Why this study may matter
This study may matter because it adds public evidence around schizophrenia. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in United States.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT06740383
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services?
This study is exploring observational follow-up for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Beth Israel Deaconess Medical Center. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve observational follow-up, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me